Minneapolis, MN, United States of America

Joseph John Belanto

This inventor holds 1 USPTO granted patent. Top assignees: Harvard College, Massachusetts Institute of Technology, The Broad Institute, Inc.. Active years: 2025.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joseph John Belanto: Innovator in CRISPR Technology

Introduction

Joseph John Belanto is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of genetic engineering, particularly through his work with CRISPR technology. His innovative approach has the potential to revolutionize plant modification and improve agricultural practices.

Latest Patents

Belanto holds a patent for "CRISPR-systems for modifying a trait of interest in a plant." This invention relates to plants that incorporate a CRISPR system or its components, including compositions, containers, polynucleotides, vectors, and delivery systems. The patent also outlines methods for producing these CRISPR systems and improving their functionality within plant cells.

Career Highlights

Throughout his career, Joseph John Belanto has worked with prestigious organizations such as the Broad Institute, Inc. and the Massachusetts Institute of Technology. His experience in these institutions has allowed him to collaborate with leading experts in the field of genetic research.

Collaborations

Some of his notable coworkers include Omar O Abudayyeh and Jonathan S Gootenberg. Their collective efforts have contributed to advancements in CRISPR technology and its applications in various fields.

Conclusion

Joseph John Belanto's work in CRISPR technology exemplifies the innovative spirit of modern science. His contributions are paving the way for future advancements in plant genetics and agricultural practices.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…